Stock RAPTOR PHARMACEUTICAL CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Raptor Pharmaceutical Corp

Equities

US75382F1066

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Raptor Pharmaceutical Corp
2016 Exclusive: Drugmaker Depomed prepares to explore a sale - sources RE

Managers

Managers TitleAgeSince
Paul Hoelscher DFI
 Director of Finance/CFO 59 16-10-24
Kim Lee IRC
 Investor Relations Contact - 14-10-22
Françoise de Craecker PRN
 Corporate Officer/Principal 62 -
David Happel PRN
 Corporate Officer/Principal 62 14-10-22

Members of the board

Members of the board TitleAgeSince
Gregg Lapointe CHM
 Chairman 65 14-12-31
Timothy Walbert BRD
 Director/Board Member 57 11-04-10
Paul Hoelscher DFI
 Director of Finance/CFO 59 16-10-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 85,306,787 79,995,700 ( 93.77 %) 0 93.77 %

Company contact information

Horizon Pharmaceutical LLC

7 Hamilton Landing Suite 100

94949, Novato

+

address Raptor Pharmaceutical Corp

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-0.49% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.31% 96.73B
ARGENX SE Stock argenx SE
+1.66% 21.31B
BIONTECH SE Stock BioNTech SE
-16.16% 21.21B
GENMAB A/S Stock Genmab A/S
-6.82% 18.79B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.41% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-22.87% 13.68B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.32% 13.44B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+21.46% 10.98B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Raptor Pharmaceutical Corp